Weerakoon Kosala G A D, Gobert Geoffrey N, Cai Pengfei, McManus Donald P
QIMR Berghofer Medical Research Institute, Brisbane, Australia School of Public Health, University of Queensland, Brisbane, Australia Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Clin Microbiol Rev. 2015 Oct;28(4):939-67. doi: 10.1128/CMR.00137-14.
Schistosomiasis is a major neglected tropical disease that afflicts more than 240 million people, including many children and young adults, in the tropics and subtropics. The disease is characterized by chronic infections with significant residual morbidity and is of considerable public health importance, with substantial socioeconomic impacts on impoverished communities. Morbidity reduction and eventual elimination through integrated intervention measures are the focuses of current schistosomiasis control programs. Precise diagnosis of schistosome infections, in both mammalian and snail intermediate hosts, will play a pivotal role in achieving these goals. Nevertheless, despite extensive efforts over several decades, the search for sensitive and specific diagnostics for schistosomiasis is ongoing. Here we review the area, paying attention to earlier approaches but emphasizing recent developments in the search for new diagnostics for schistosomiasis with practical applications in the research laboratory, the clinic, and the field. Careful and rigorous validation of these assays and their cost-effectiveness will be needed, however, prior to their adoption in support of policy decisions for national public health programs aimed at the control and elimination of schistosomiasis.
血吸虫病是一种主要的被忽视的热带病,在热带和亚热带地区折磨着超过2.4亿人,其中包括许多儿童和年轻人。该疾病的特点是慢性感染,伴有严重的残留发病率,具有相当大的公共卫生重要性,对贫困社区产生重大的社会经济影响。通过综合干预措施降低发病率并最终消除该病是当前血吸虫病控制项目的重点。在哺乳动物和蜗牛中间宿主中对血吸虫感染进行精确诊断,将在实现这些目标中发挥关键作用。然而,尽管几十年来付出了巨大努力,但寻找血吸虫病敏感和特异诊断方法的工作仍在继续。在此,我们对该领域进行综述,关注早期方法,但着重强调在寻找具有实际应用价值的血吸虫病新诊断方法方面的最新进展,这些新方法可应用于研究实验室、临床和现场。然而,在将这些检测方法用于支持旨在控制和消除血吸虫病的国家公共卫生项目的政策决策之前,需要对其进行仔细而严格的验证及其成本效益分析。